RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 48 filers reported holding RECRO PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $765,141 | -57.9% | 1,631,431 | -1.2% | 0.00% | -60.0% |
| Q2 2023 | $1,816,869 | -7.1% | 1,651,699 | +0.5% | 0.01% | 0.0% |
| Q1 2023 | $1,956,715 | -1.2% | 1,644,298 | +23.7% | 0.01% | 0.0% |
| Q4 2022 | $1,979,900 | +19.2% | 1,328,792 | +30.4% | 0.01% | 0.0% |
| Q3 2022 | $1,661,000 | +139.0% | 1,019,078 | +16.5% | 0.01% | +150.0% |
| Q2 2022 | $695,000 | -56.8% | 874,653 | -2.0% | 0.00% | -50.0% |
| Q1 2022 | $1,607,000 | +82.2% | 892,683 | +73.1% | 0.00% | +100.0% |
| Q4 2021 | $882,000 | +191.1% | 515,596 | +250.1% | 0.00% | +100.0% |
| Q3 2021 | $303,000 | +818.2% | 147,260 | +929.8% | 0.00% | – |
| Q2 2021 | $33,000 | – | 14,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 2,202,420 | $6,145,000 | 3.11% |
| Samjo Capital LLC | 560,000 | $1,562,000 | 1.16% |
| MAK CAPITAL ONE LLC | 1,224,264 | $3,416,000 | 0.81% |
| Cowen Prime Services LLC | 470,500 | $1,313,000 | 0.50% |
| Portolan Capital Management | 1,957,283 | $5,461,000 | 0.43% |
| Parkman Healthcare Partners LLC | 601,967 | $1,679,000 | 0.39% |
| Rubric Capital Management LP | 1,076,587 | $3,004,000 | 0.18% |
| Frontier Wealth Management LLC | 49,112 | $2,142,000 | 0.16% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 466,992 | $1,303,000 | 0.16% |
| AWM Investment Company, Inc. | 391,304 | $1,092,000 | 0.12% |